Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Sera Prognostics, Inc. (SERA)
:SERA
SERA Stock Chart & Stats
Day’s Range― - ―
52-Week Range$3.84 - $12.36
Previous CloseN/A
Volume57.63K
Average Volume (3M)138.16K
Market Cap
$149.55M
Enterprise Value$212.82M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.37
Next Earnings
Mar 19, 2025EPS Estimate
-0.24Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.99
Shares Outstanding34,054,740
10 Day Avg. Volume204,265
30 Day Avg. Volume138,159
Standard Deviation0.44
R-Squared0.00801
Alpha0.04
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)1534.13
Price to Cash Flow (P/CF)-5.20
P/FCF Ratio0.00
Enterprise Value/Market Cap1.42
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit2.22K
Enterprise Value/Ebitda-6.81
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusModerate Buy
Number of Analyst Covering1
---
Sera Prognostics News
PremiumCompany Announcements
Sera Prognostics Announces $50 Million Public Offering
PremiumCompany Announcements
Sera Prognostics Highlights PreTRM Test in Investor Update
PremiumCompany Announcements
Sera Prognostics Highlights PreTRM® at Healthcare Conference
PremiumCompany Announcements
Sera Prognostics Advances Maternal Health Research Initiatives
PremiumCompany Announcements
Sera Prognostics Faces Business Continuity Risks Amid Data DependencyPremiumCompany Announcements
Sera Prognostics Reports Strategic Moves Amid Revenue Decline---
Bulls Say, Bears Say
Bulls Say
Commercialization StrategyManagement continues to plan appropriately for the release and ensuing commercialization strategy, and remains enthusiastic about the study's efficacy and resultant opportunity for PreTRM.
Market PositionSERA is well-positioned to ramp revenue organically or through a partner.
Bears Say
Financial PerformanceThe financial results were uneventful with revenue of $29K versus the expected $75K.
Publication DelayThe peer-reviewed paper showcasing data from PRIME, the pivotal trial for PreTRM/reimbursement, was pushed to Spring '25.
Revenue ForecastRevenue for 2024 is trimmed to $120K on low PreTRM take up ahead of reimbursement.
---
Ownership Overview
7.30% Insiders
7.00% Mutual Funds
5.75% Other Institutional Investors
73.20% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
SERA FAQ
What was Sera Prognostics, Inc.’s price range in the past 12 months?
Sera Prognostics, Inc. lowest stock price was $3.84 and its highest was $12.36 in the past 12 months.
What is Sera Prognostics, Inc.’s market cap?
Sera Prognostics, Inc.’s market cap is $149.55M.
When is Sera Prognostics, Inc.’s upcoming earnings report date?
Sera Prognostics, Inc.’s upcoming earnings report date is Mar 19, 2025 which is in 24 days.
How were Sera Prognostics, Inc.’s earnings last quarter?
Sera Prognostics, Inc. released its earnings results on Nov 06, 2024. The company reported -$0.24 earnings per share for the quarter, missing the consensus estimate of -$0.219 by -$0.021.
Is Sera Prognostics, Inc. overvalued?
According to Wall Street analysts Sera Prognostics, Inc.’s price is currently Overvalued.
Does Sera Prognostics, Inc. pay dividends?
Sera Prognostics, Inc. does not currently pay dividends.
What is Sera Prognostics, Inc.’s EPS estimate?
Sera Prognostics, Inc.’s EPS estimate is -0.24.
How many shares outstanding does Sera Prognostics, Inc. have?
Sera Prognostics, Inc. has 34,054,740 shares outstanding.
What happened to Sera Prognostics, Inc.’s price movement after its last earnings report?
Sera Prognostics, Inc. reported an EPS of -$0.24 in its last earnings report, missing expectations of -$0.219. Following the earnings report the stock price went down -12.7%.
Which hedge fund is a major shareholder of Sera Prognostics, Inc.?
Currently, no hedge funds are holding shares in SERA
---
Sera Prognostics Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
― (―)
― (―)
Blogger Sentiment
Bullish
SERA Sentiment 70%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 11.8K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $415.2K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.9%
Last 30 Days ▼ 5.7%
Last 30 Days ▼ 5.7%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-56.44%
12-Months-Change
Fundamentals
Return on Equity
-49.58%
Trailing 12-Months
Asset Growth
-12.28%
Trailing 12-Months
Company Description
Sera Prognostics, Inc.
Sera Prognostics Inc is a health diagnostic company. It develops diagnostic tests for the early prediction of a woman's individualized risk of premature birth, preeclampsia, and other pregnancy complications.
---
SERA Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlighted significant achievements in clinical trial results, increased awareness and engagement, and a strong cash position. However, there were challenges such as decreased net revenue and increased operating expenses. The company is optimistic about future growth and is actively working on achieving the prerequisites for revenue expansion.Read More>---
SERA Stock 12 Month Forecast
Average Price Target
―Technical Analysis
Best Analysts Covering SERA
1 Year
1 Year Success Rate
1/7 ratings generated profit
1 Year Average Return
+0.56%
reiterated a buy rating 20 days ago
Copying Daniel Brennan's trades and holding each position for 1 Year would result in 14.29% of your transactions generating a profit, with an average return of +0.56% per trade.
---